08:49 AM EDT, 05/14/2025 (MT Newswires) -- Crescita Therapeutics ( CRRTF ) on Wednesday said its first-quarter net loss widened as revenue fell.

The company, which specializes in dermatology products, said the net loss increased to $932,000, from $626,000 in the prior year period.

Revenue fell to $3.54 million, from $5 million, over the same period. The Manufacturing and Services segment recorded the largest decrease in revenue, to $830,000, from $2.46 million.

"As anticipated, our Q1 results were less than the prior year, mainly due to the timing of order fulfillment in our Manufacturing segment. A large purchase order was fulfilled in Q1-2024 whereas some deliveries originally scheduled for Q1-2025 were advanced into Q4-2024," said Chief Executive Serge Verreault. "We do, however, expect topline improvement in the coming quarters as we begin delivering on larger scheduled orders."